Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study
This case-control study has shown interesting results regarding the dosage of urinary urodilatin in patients with RSW, with potentially clarifying implications both regarding the pathogenesis of this syndrome and regarding the diagnosis and therefore the clinical management of patients.
Authors
- Rosario Luca Norrito (ORCID: https://orcid.org/0000-0003-1297-5860)
- Antonino Tuttolomondo (ORCID: https://orcid.org/0000-0001-6440-7318)
- Rosaria Pecoraro
- Carlo Maida (ORCID: https://orcid.org/0000-0002-4868-9033)
- Rosaria Vincenza Giglio (ORCID: https://orcid.org/0000-0002-7968-1480)
- Vittoriano Della Corte (ORCID: https://orcid.org/0000-0002-4334-7712)
- Marco Cataldi
- Marcello Ciaccio (ORCID: https://orcid.org/0000-0001-6120-9041)
- Luisa Agnello (ORCID: https://orcid.org/0000-0003-3458-0421)
- Mario Daidone (ORCID: https://orcid.org/0000-0003-1413-5945)
- Caterina Maria Gambino (ORCID: https://orcid.org/0000-0003-2937-3428)
- Fabio Del Ben (ORCID: https://orcid.org/0000-0002-1880-0669)
Institutions
- National Cancer Institute (UA)
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fphar.2025.1579699
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00